Photograph of Eric Obscherning View LinkedIn page Download V-card

Eric Obscherning

C&M International Associate Director
1001 Pennsylvania Avenue NW
Washington, DC 20004-2595

Eric Obscherning is an associate director at C&M International where he supports the firm’s global health practice, advising Fortune 100 biopharmaceutical and medical device companies and their trade associations as they enter emerging markets, navigate policies and regulations, and develop strategic initiatives and public-private partnerships. He works at the intersection of business strategy, public policy, and government affairs on issues related to life sciences innovation, rare diseases, vaccines confidence, healthcare financing, HPV and cervical cancer, tuberculosis, antimicrobial resistance, and regulatory harmonization.

Prior to joining C&M International, Eric was a consultant with Manchester Trade, involved in corporate social responsibility at GlobalGiving, and an early employee of an aquaponics startup. His written work has appeared in Governance in an Emerging New World (Hoover Institution Press), Climate Change & Public Health (Oxford University Press), Journal of the American Medical Association, and Global Heart. He received a BS in biology and English and a Certificate in Global Health from the University of Wisconsin-Madison, and studied NCDs and precision medicine at the U.S. National Institutes of Health.


  • University of Wisconsin – Madison, B.S. biology and English
  • University of Wisconsin – Madison, Certificate global health
  • American University Washington College of Law, Certificate WTO and U.S. trade law and policy
  • U.S. National Institutes of Health, Foundation for Advanced Education in the Sciences


View More

"Measuring Progress of Regulatory Convergence and Cooperation Among Asia–Pacific Economic Cooperation (APEC) Member Economies in the Context of the COVID-19 Pandemic," Therapeutic Innovation & Regulatory Science (March 17, 2021). Co-Author: Eric Obscherning & Patricia L. Wu.
"Health Challenges Unite Asia Pacific Leaders in Effort to Close Gaps in Economic Recovery," (December 1, 2020). Contacts: Robert Holleyman, Patricia L. Wu, Ryan MacFarlane, Eric Obscherning
Client Alert / Newsletter
"Coronavirus: APEC Health Cooperation Imperative as Economic Integration and Interdependence Grows in the Presence of Health Threats," (February 7, 2020). Contacts: Robert Holleyman, Patricia L. Wu, Eric Obscherning, Ryan MacFarlane, Joshua Boswell
Client Alert / Newsletter
"World Leaders Call for Accelerated Progress Towards Universal Health Coverage," Regulatory Alert (September 23, 2019). Contacts: Patricia L. Wu, Eric Obscherning, Ryan MacFarlane, Joshua Boswell
Client Alert / Newsletter
"The Month in International Trade – June 2019," International Trade Bulletin (July 10, 2019). Contacts: Jeffrey L. Snyder, Frances P. Hadfield, Edward Goetz, John B. Brew, Robert Holleyman, Andrew Blasi, Eric Obscherning, Thomas A. Lorenzen, Daniel W. Wolff, Amanda Shafer Berman, John E. McCarthy Jr., Anuj Vohra
Client Alert / Newsletter
"Addressing Ethical Quandaries in Undergraduate Student-Led Global Health Trips," Health and Human Rights, Special Section on Global Health Fieldwork, Volume 21, Issue 1 (June 2019). Co-Author: Eric Obscherning.
"Africa Trade and Technology," Governance in an Emerging New World, Winter Series, Issue 19 (January 14, 2019). Co-Author: Eric Obscherning.
"A Global Social Network to Catalyze Solutions for Chronic NCD: A Case Study on the Young Professionals Chronic Disease Network," Global Heart, Volume 11, Issue 4 (December 2016). Co-Author: Eric Obscherning.
"Applying Climate Change Science for Public Health," Climate Change and Public Health, Chapter 2, Oxford University Press (2015). Co-Author: Eric Obscherning.

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia that represents clients in litigation and arbitration, regulatory and policy, and transactional and corporate matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation and government-facing matters, as well as its ongoing commitment to pro bono service and diversity, equity, and inclusion.

View Desktop Site | Mobile Sitemap |

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2021
Attorney advertising - prior results do not guarantee a similar outcome.